Telesis Bio, Inc.
NASDAQ:TBIO
1.11 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1.745 | 30.419 | 82.806 | 13.463 | 29.144 | 55.199 | 48.058 | 57.729 |
| Short Term Investments
| 17.588 | 13.159 | 0 | 0 | 0 | 88.904 | 9.997 | 12.992 |
| Cash and Short Term Investments
| 19.333 | 43.753 | 82.806 | 13.463 | 29.144 | 144.103 | 58.055 | 70.721 |
| Net Receivables
| 5.985 | 5.851 | 3.665 | 2.266 | 1.492 | 0 | 0 | 0 |
| Inventory
| 4.025 | 2.2 | 2.368 | 0.601 | 0.712 | 0 | 0 | 0 |
| Other Current Assets
| 1.008 | 3.288 | 4.345 | 0.851 | 0.086 | 5.499 | 4.98 | 1.717 |
| Total Current Assets
| 30.351 | 55.092 | 93.184 | 17.181 | 31.434 | 149.602 | 63.035 | 72.438 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 34.52 | 8.521 | 5.737 | 3.779 | 0.888 | 10.245 | 6.778 | 4.859 |
| Goodwill
| 3.497 | 14.886 | 14.33 | 3.497 | 3.497 | 21.359 | 21.359 | 21.359 |
| Intangible Assets
| 1.367 | 1.882 | 2.397 | 2.325 | 2.861 | 106.445 | 106.842 | 106.842 |
| Goodwill and Intangible Assets
| 4.864 | 16.768 | 16.727 | 5.822 | 6.358 | 127.804 | 128.201 | 128.201 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.676 | 0.981 | 0.609 | 0.081 | 0.081 | 0 | 0.533 | 0.065 |
| Total Non-Current Assets
| 40.06 | 26.27 | 23.073 | 9.682 | 7.327 | 138.049 | 135.512 | 133.125 |
| Total Assets
| 70.411 | 81.362 | 116.257 | 26.863 | 38.761 | 287.651 | 198.547 | 205.563 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 3.284 | 1.295 | 2.499 | 1.191 | 0.614 | 5.168 | 4.594 | 0.462 |
| Short Term Debt
| 1.822 | 0.637 | 1.84 | 2.116 | 0.111 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.338 | 3.958 | 0.205 | 0.606 | 0.112 | 2.572 | 0 | 0 |
| Other Current Liabilities
| 2.74 | 7.608 | 5.189 | 1.712 | 0.885 | 6.547 | 7.491 | 11.546 |
| Total Current Liabilities
| 8.184 | 13.498 | 9.733 | 5.625 | 1.722 | 14.287 | 12.085 | 12.008 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 5.269 | 20.79 | 15.482 | 6.21 | 4.657 | -34.582 | 0 | 0 |
| Deferred Revenue Non-Current
| 0.095 | 0.142 | 0.15 | 0.04 | 0.033 | 41.841 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 27.289 | 0 | 0 | 0 | 0 | 0.481 | 6.039 | 18.52 |
| Other Non-Current Liabilities
| 0.036 | 0.367 | 0.108 | 40.447 | 39.852 | 140.329 | 273.938 | 213.625 |
| Total Non-Current Liabilities
| 32.689 | 21.299 | 15.74 | 46.697 | 44.542 | 148.069 | 279.977 | 232.145 |
| Total Liabilities
| 40.873 | 34.797 | 25.473 | 52.322 | 46.264 | 162.356 | 292.062 | 244.153 |
| Equity: | ||||||||
| Preferred Stock
| 29.3 | 0 | 0 | 38.914 | 38.914 | 0 | 0 | 0 |
| Common Stock
| 0.005 | 0.005 | 0.005 | 0.002 | 0.002 | 0.045 | 0.01 | 0.009 |
| Retained Earnings
| -161.465 | -113.741 | -65.27 | -26.312 | -8.302 | -246.203 | -148.808 | -82.365 |
| Accumulated Other Comprehensive Income/Loss
| -0.005 | -0.003 | 0 | -38.914 | -38.914 | 0.196 | 0.079 | 0 |
| Other Total Stockholders Equity
| 161.703 | -0.002 | 156.049 | 0.851 | 0.797 | 371.257 | 55.204 | 43.766 |
| Total Shareholders Equity
| 29.538 | -113.741 | 90.784 | -25.459 | -7.503 | 125.295 | -93.515 | -38.59 |
| Total Equity
| 29.538 | -113.741 | 90.784 | -25.459 | -7.503 | 125.295 | -93.515 | -38.59 |
| Total Liabilities & Shareholders Equity
| 70.411 | -78.944 | 116.257 | 26.863 | 38.761 | 287.651 | 198.547 | 205.563 |